| Oct 24 |
A new paradigm in electrophysiology: Medtronic receives FDA approval of Affera™ Mapping and Ablation System and Sphere-9™ Catheter
|
| Oct 24 |
Medtronic’s Prevail DCB pivotal trial receives FDA IDE approval
|
| Oct 23 |
International Revenue Growth Makes Medtronic (MDT) An Attractive Investment For Conservative Investors
|
| Oct 22 |
Medtronic (MDT) Increases Despite Market Slip: Here's What You Need to Know
|
| Oct 21 |
FDA greenlights add-ons for Boston Scientific’s Farapulse field ablation system
|
| Oct 21 |
MDT vs. ABT: Which Stock Is the Better Value Option?
|
| Oct 19 |
Does Medtronic plc's (NYSE:MDT) Weak Fundamentals Mean That The Market Could Correct Its Share Price?
|
| Oct 16 |
Boston Scientific: evolving the cardiac rhythm management space
|
| Oct 15 |
Medtronic to evaluate Affera in ventricular tachycardia
|
| Oct 14 |
FDA approves Medtronic’s Affera system for VT treatment study
|
